BNET Industries
Ventana Medical Systems Inc. is in the Health Care Industry
Latest News and Analysis
VMSI, GMFX, TCHH, KLNDF, WDRP, CADD Have Also Been Removed From Naked Short List Today.
M2 PRESSWIRE-20 February 2008-BUYINS.NET: VMSI, GMFX, TCHH, KLNDF, WDRP, CADD Have Also Been Removed From Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:20022008 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked...
Aruba shares take tumble
Shares of networking equipment maker Aruba Networks Inc. of Sunnyvale fell $2.84, or 36.6 percent, to $4.92 Friday, which is the biggest drop since its March initial public offering. The maker of wireless networking equipment said in a statement of preliminary results that second-quarter revenue was as much as $41...
Ventana Responds to Extension of Roche's Unsolicited Tender Offer
Discussions with Roche Continue Under Confidentiality Agreement TUCSON, Ariz. -- Ventana Medical Systems, Inc. (NASDAQ: VMSI), the global leader in tissue-based cancer diagnostics, today responded to Roche's fifth extension of its unsolicited tender offer to acquire all outstanding shares of Ventana for $75.00 in cash per common share. ...
Ventana Enters into Confidentiality Agreement with Roche
TUCSON, Ariz. -- Ventana Medical Systems, Inc. (NASDAQ: VMSI), the global leader in tissue-based cancer diagnostics, today announced it has entered into a confidentiality agreement with Roche. The agreement will allow Roche to commence due diligence and have appropriate access to non-public information regarding Ventana to better understand the Company's...
Ventana Reports Third Quarter Results
* Net sales increased 28% to $75.7 million; company receives 20 Symphony orders in the third quarter * GAAP net income, including previously announced litigation developments, advisory costs related to the Roche unsolicited offer and the Spring BioScience acquisition was $0.3 million or $0.01 per diluted share *...
Speak with other shareholders about: (OTCBB: SLWF), (NASDAQ: MSFT), (OTC: NSRGY), and (OTC: RHHBY) .
M2 PRESSWIRE-9 July 2007-Stockwire.com: Speak with other shareholders about: (OTCBB: SLWF), (NASDAQ: MSFT), (OTC: NSRGY), and (OTC: RHHBY) .C1994-2007 M2 COMMUNICATIONS LTD RDATE:09072007 AUSTIN, TX - Are you looking to speak with other investors about your favorite stock? Stockwire.com, ranked in...
Court Rules Against Digene in HPV Patent Infringement Case
Ventana Medical Systems, Inc. (NASDAQ: VMSI) today announced the U.S. District Court in Delaware ruled in favor of Ventana Medical Systems, Inc. by denying the motion of Digene Corporation seeking a preliminary injunction against Ventana. Digene had sought an injunction to stop the manufacture, sale or use of Ventana...
Research and Markets: Gain Insight into Deals and Alliances at Specialist Medical Technology Company: Ventana Medical Systems Inc
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c52399) has announced the addition of Ventana Medical Systems Inc - Deals and Alliances Report to their offering.
First Symphony High Definition H&E Study Published
Ventana Medical Systems, Inc. (NASDAQ: VMSI) today announced the results of a multi-center study across 120 cases of prostatic carcinoma comparing Symphony High Definition H&E slide staining to routine H&E staining methods. The study, conducted by Dr. Jonathan Epstein of Johns Hopkins Hospital, concluded that, "The underdiagnosis of limited...
Ventana Clarifies Outlook
Ventana Medical Systems, Inc. (NASDAQ: VMSI), today clarified that previously announced preliminary earnings guidance of approximately $0.86 for 2006 and approximately $1.19 for 2007 includes stock option expense of approximately $0.09 per share in both periods. ABOUT VENTANA Ventana develops, manufactures, and markets instrument/reagent systems that automate tissue...
Application Submitted for Scheme of Arrangement Meetings to Approve Ventana's Acquisition of Vision Systems
TUCSON, Arizona -- Ventana Medical Systems, Inc. (NASDAQ: VMSI) today announced that Vision Systems Limited (ASX: VSL) has submitted an application to the Supreme Court of Victoria in Australia seeking orders to convene on November 2, 2006, the Scheme of Arrangement meetings for Ventana's acquisition of Vision. In separate meetings...
Ventana Announces Symphony Commercial Launch
Ventana Medical Systems, Inc. (NASDAQ: VMSI) today announced the commercial launch of its fully automated Symphony H&E, or primary staining system for use in clinical histology and drug discovery laboratories. Commenting on the launch, Christopher Gleeson, President and CEO, said, "We are pleased to have reached this important milestone...
TriPath Imaging Receives FDA 510(k) Clearance for Estrogen Receptor and Progesterone Receptor Applications for Ventana Image Analysis System
TriPath Imaging, Inc. (NASDAQ: TPTH), and Ventana Medical Systems, Inc. (NASDAQ: VMSI) announced today TriPath Imaging has received 510k clearance from the U.S. Food and Drug Administration for the Ventana Image Analysis System VIAS when used with tissues stained for Estrogen Receptor ER and Progesterone Receptor PR. As previously...
Ventana Obtains Summary Judgment in Biogenex Litigation
Ventana Medical Systems, Inc. (NASDAQ: VMSI), announced today the U.S. District Court for the Northern District of California San Jose Division has issued summary judgment rulings in favor of Ventana in the BioGenex v. Ventana litigation. Ventana was successful in obtaining a judgment of noninfringement of BioGenex' U.S. Patent...
Ventana Expects Higher Sales and EPS in Fourth Quarter 2004
Ventana Medical Systems, Inc. (NASDAQ: VMSI), today announced higher-than-expected preliminary fourth quarter sales of approximately $48 million, driven by strong growth in both instrument and consumable sales. Instrument sales were very strong and contributed to the majority of the higher-than-expected revenues. As a result, the Company expects to...
Ventana Medical Systems, Inc. [VMSI] President and CEO to Open The NASDAQ Stock Market
What:
Ventana to Present at Merrill Lynch Med Tech Fundamentals Conference
Ventana Medical Systems, Inc. (NASDAQ: VMSI), today announced its President and Chief Executive Officer Christopher Gleeson will be one of the panelists discussing diagnostics at the Merrill Lynch Med Tech Fundamentals Conference on Wednesday, November 17, in New York. Ventana develops, manufactures, and markets instrument/reagent systems that automate slide...
Ventana and Quantum Dot Announce Agreement
TUCSON, Ariz. & HAYWARD, Calif. -- Ventana Medical Systems, Inc. (Nasdaq:VMSI), and Quantum Dot Corporation QDC announced comprehensive licensing and supply agreements relating to QDC's QdotR nanocrystal technology for in vitro diagnostic applications in Anatomic Pathology and Cytology. Ventana will also incorporate QDC technology in its research and pharmaceutical discovery...
Armed Forces Institute of Pathology Partners with Ventana Medical Systems Inc
Business Editors/Health/Medical Writers
Ventana to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
Business Editors/Health/Medical Writers TUCSON, Ariz.--BUSINESS WIRE--Jan. 30, 2003 Ventana Medical Systems Inc. (NASDAQ: VMSI), today announced that its President and Chief Executive Officer, Chris Gleeson, will present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference, to be held in New York. Gleeson will present...
- Next »
- page 1 of 2
- « Previous
Sort byClose
Industry Transcripts by Seeking Alpha
-
Synovis Life Technologies, Inc. F4Q08 (Qtr End 10/31/08) Earnings Call Transcript
on Dec 03, 2008about SYNO
-
Landauer, Inc. F4Q08 (Qtr End 9/30/08) Earnings Call Transcript
on Dec 02, 2008about LDR
-
Landauer, Inc. F4Q08 (Qtr End 9/30/08) Earnings Call Transcript
on Dec 02, 2008about LDR
-
Thermage Inc. Q3 2008 Earnings Call Transcript
on Dec 01, 2008about THRM
-
Allied Healthcare International Inc. F4Q08 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 25, 2008about AHCI
Ventana Medical Systems Inc. Company Info
NAICS Code
Surgical and Medical Instrument Manufacturing: 339112
